Cargando…
Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer
OBJECTIVE: To determine the frequency of pathogenic mutations in high-penetrance genes (HPGs) in patients with non–small cell lung cancer (NSCLC) and identify whether such mutations are associated with clinicopathologic outcomes. METHODS: Patients with NSCLC who had consented to participate in a lin...
Autores principales: | Krantz, Seth B., Zeeshan, Kanwal, Kuchta, Kristine M., Hensing, Thomas A., Mangold, Kathy A., Zheng, S. Lilly, Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801288/ https://www.ncbi.nlm.nih.gov/pubmed/36590722 http://dx.doi.org/10.1016/j.xjon.2022.09.001 |
Ejemplares similares
-
Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022) -
Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexity
por: Feldman, Hope A., et al.
Publicado: (2022) -
Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
por: Peng, Terrance, et al.
Publicado: (2022)